Page last updated: 2024-12-10

ck-869

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3574452
CHEMBL ID3261538
SCHEMBL ID19399667
MeSH IDM0589692

Synonyms (29)

Synonym
EU-0093645
CHEMDIVAM_000348
CHEMDIV1_012738
HMS623C22
AKOS002089815
2-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)-1,3-thiazolidin-4-one
CCG-33400
S6954
CHEMBL3261538
AKOS021653521
ck-869 ,
388592-44-7
ck 869
ck-0157869
2-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)-4-thiazolidinone
sr-01000553731
SR-01000553731-1
SCHEMBL19399667
2-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)thiazolidin-4-one
HY-16927
CS-0012974
BS-17180
ck869
EX-A2784
BCP29868
ck 869; ck869; ck-0157869; ck 0157869; ck0157869
D80737
2-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)-4-
AC-35688
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1143069Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay2014European journal of medicinal chemistry, Jun-10, Volume: 80Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
AID1143070Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay2014European journal of medicinal chemistry, Jun-10, Volume: 80Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.39 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]